BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 19362968)

  • 1. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
    Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
    Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience.
    Danesin N; Bonaldi L; Martines A; Nalio S; Bertorelle R; Compagno S; Marcato R; Manni S; Scarmozzino F; Pizzi M; Tos APD; Cellini A; Scapinello G; Visentin A; Trentin L; Piazza F
    Ann Hematol; 2024 Apr; ():. PubMed ID: 38687347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.
    Sekiguchi N; Nomoto J; Nagata A; Kiyota M; Fukuda I; Yamada K; Takezako N; Kobayashi Y
    Biomed Res Int; 2018; 2018():6728128. PubMed ID: 30402490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waldenstrom's Macroglobulinemia: An Update.
    Mazzucchelli M; Frustaci AM; Deodato M; Cairoli R; Tedeschi A
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018004. PubMed ID: 29326801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Glycosylation on Effector Functions of Therapeutic IgG.
    Abès R; Teillaud JL
    Pharmaceuticals (Basel); 2010 Jan; 3(1):146-157. PubMed ID: 27713246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene mutations connected to Waldenstöm macroglobulinemia].
    Kutálková K; Sedlaříková L; Adam Z; Ševčíková S
    Vnitr Lek; 2016 Jan; 62(1):40-3. PubMed ID: 26967235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
    Chang H; Qi X; Xu W; Reader JC; Ning Y
    Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
    Ocio EM; Schop RF; Gonzalez B; Van Wier SA; Hernandez-Rivas JM; Gutierrez NC; Garcia-Sanz R; Moro MJ; Aguilera C; Hernandez J; Xu R; Greipp PR; Dispenzieri A; Jalal SM; Lacy MQ; Gonzalez-Paz N; Gertz MA; San Miguel JF; Fonseca R
    Br J Haematol; 2007 Jan; 136(1):80-6. PubMed ID: 17222197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
    Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
    Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
    Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
    Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
    Chang H; Qi C; Trieu Y; Jiang A; Young KH; Chesney A; Jani P; Wang C; Reece D; Chen C
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):36-8. PubMed ID: 19362968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromosomal abnormalities and Waldenström macroglobulinemia].
    Berger R; Nguyen-Khac F
    Pathol Biol (Paris); 2008 Sep; 56(6):400-6. PubMed ID: 18456427
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.